Xintiandi: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Xintiandi: Legal Opinions of Beijing Tianyuan Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Xintiandi Pharmaceutical Co., Ltd.
Newland Pharmaceutical: Correction announcement regarding the notice of convening the first extraordinary shareholders' meeting in 2024.
Newland Pharmaceutical: Announcement on the Disclosure of 2024 Half-Year Report
Newland Pharmaceutical: Summary table of non-operational fund occupancy and other related fund transactions in the first half of 2024.
Newland Pharmaceutical: Notice of the first temporary shareholder meeting in 2024
Newland Pharmaceutical: New World Pharma Co., Ltd. 2024 interim financial report.
Newland Pharmaceutical: Announcement Regarding Changes to the Company's Pharmaceutical Production License
Newland Pharmaceutical: Announcement Regarding Obtaining the "Henan Province Enterprise Investment Project Filing Certificate".
Newland Pharmaceutical: Announcement on changes in the company's pharmaceutical production license
Xintiandi: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Xintiandi: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Xintiandi: Announcement on the completion of the general election of the board of directors and the board of supervisors and the appointment of senior managers
Xintiandi: An indicative announcement on the disclosure of the report for the first quarter of 2024
Xintiandi: Board Nomination Committee's Review Opinions on the Appointment of Senior Executives
Xintiandi: Legal Opinions of Beijing Tianyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Xintiandi Pharmaceutical Co., Ltd.
Xintiandi: Announcement on Obtaining a Notice of Approval of the Application for the Marketing of Chemical Ingredients
Xintiandi: Corrected Notice Concerning the Notice of Convening the 2023 Annual General Meeting of Shareholders
Xintiandi: Summary table on the use of non-operating capital and other related capital transactions
Xintiandi: Notice on Convening the 2023 Annual General Meeting of Shareholders
No Data
No Data